Search bioRxivSearch

bioRxiv · 10.1101/655738

Untangling the Relatedness among Correlations, Part III: Inter-Subject Correlation Analysis through Bayesian Multilevel Modeling for Naturalistic Scanning

Abstract

While inter-subject correlation (ISC) analysis is a powerful tool for naturalistic scanning data, drawing appropriate statistical inferences is difficult due to the daunting task of accounting for the intricate relatedness in data structure as well as the intricacy of handling the multiple testing issue. In our previous work we proposed nonparametric approaches to performing group ISC analysis through bootstrapping for one group of subjects and permutation testing for two groups (Chen et al., 2016). A more flexible methodology is to parametrically build a linear mixed-effects (LME) model that captures the relatedness embedded in the data (Chen et al., 2017); in addition, the LME approach also has the capability of incorporating explanatory variables such as subject-grouping factors and quantitative covariates. However, the whole-brain LME modeling methodology still faces some challenges. When an LME model becomes sophisticated, it becomes difficult or even impossible to assign accurate degrees of freedom for each testing statistic. In addition, the typical correction methods for multiple testing through spatial extent tend to be over-penalizing, and dichotomous decisions through thresholding under null hypothesis significance testing (NHST) are controversial in general and equally problematic in neuroimaging as well. For instance, the popular practice of only reporting \"statistically significant\" results in neuroimaging not only wastes data information, but also distorts the full results as well as perpetuates the reproducibility crisis because of the fact that the difference between a \"significant\" result and a \"non-significant\" one is not necessarily significant.\n\nHere we propose a Bayesian multilevel (BML) framework for ISC data analysis that integrates all the spatial elements (i.e., regions of interest) into one model. By loosely constraining the regions through a weakly informative prior, BML conservatively pools the effect of each region toward the center, and improves collective fitting and overall model performance. The BML paradigm leverages the commonality or similarity among brain regions and the information across multiple levels embedded in the hierarchical data structure instead of leveraging the spatial extent adopted in the conventional correction method for multiple testing. In addition to potentially achieving a higher inference efficiency than the conventional LME approach, BML improves spatial specificity and easily allows the investigator to adopt a philosophy of full results reporting (instead of dichotomizing into \"significant\" and \"non-significant\" results), thus minimizing loss of information while enhancing reproducibility. A dataset of naturalistic scanning is utilized to illustrate the modeling approach with 268 parcels and to showcase the modeling capability, flexibility and advantages in reports reporting. The associated program will be available as part of the AFNI suite for general use.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Chen, G., Taylor, P. A., Qu, X., Molfese, P. J., Bandettini, P. A., Cox, R. W., Finn, E. S.. 2019-05-30. Untangling the Relatedness among Correlations, Part III: Inter-Subject Correlation Analysis through Bayesian Multilevel Modeling for Naturalistic Scanning. https://doi.org/10.1101/655738

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience